Enchantment State News

News Alert from KRQE

WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.

A Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that’s been very rare in teens and young adults who get a much higher dose.

    

               

    COMPLETE LOCAL COVID-19 RESOURCE GUIDE →   Tracking statistics/maps, testing sites, public health order, re-opening plans?      

Original source can be found here.